Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes

Value in Health ◽

10.1016/j.jval.2013.03.819 ◽

2013 ◽

Vol 16 (3) ◽

pp. A164

Author(s):

P.D. Home ◽

P. Soewondo ◽

Z. Hussein ◽

A.A. Shafie ◽

K. AlRaddady ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Switching Therapy ◽

Short And Long Term

Download Full-text

Short And Long-Term Cost-Effectiveness Of Switching Therapy From Insulin Glargine To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes In Saudi Arabia And India

Value in Health ◽

10.1016/j.jval.2013.03.820 ◽

2013 ◽

Vol 16 (3) ◽

pp. A164

Author(s):

P.D. Home ◽

P. Soewondo ◽

A.A. Shafie ◽

K. AlRaddady ◽

R. Baadbad ◽

...

Keyword(s):

Type 2 Diabetes ◽

Saudi Arabia ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Switching Therapy ◽

Short And Long Term

Download Full-text

Short And Long-Term Cost-Effectiveness Of Starting Biphasic Insulin Aspart 30 In Insulin-Naïve People With Type-2 Diabetes

Value in Health ◽

10.1016/j.jval.2013.03.821 ◽

2013 ◽

Vol 16 (3) ◽

pp. A164

Author(s):

P.D. Home ◽

P. Soewondo ◽

Z. Hussein ◽

A.A. Shafie ◽

K. AlRaddady ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Short And Long Term

Download Full-text

An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naïve people with poorly controlled type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2014.08.024 ◽

2014 ◽

Vol 106 (2) ◽

pp. 319-327 ◽

Author(s):

Asrul Akmal Shafie ◽

Vishal Gupta ◽

Ranya Baabbad ◽

Eva Hammerby ◽

Philip Home

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Short And Long Term

Download Full-text

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

Value in Health ◽

10.1016/s1098-3015(10)75002-6 ◽

2009 ◽

Vol 12 (7) ◽

pp. A405-A406

Author(s):

E Suchankova ◽

T Doležal ◽

Z Pisarikova ◽

K Rychna ◽

D Bartaskova

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Cost Effectiveness Analysis ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Effectiveness Analysis ◽

Biphasic Insulin Aspart 30

Download Full-text

An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes

Journal of Medical Economics ◽

10.3111/13696998.2014.991791 ◽

2015 ◽

Vol 18 (4) ◽

pp. 263-272 ◽

Author(s):

Vishal Gupta ◽

Ranya Baabbad ◽

Eva Hammerby ◽

Annie Nikolajsen ◽

Asrul Akmal Shafie

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Neutral Protamine Hagedorn ◽

Download Full-text

DB1 EVALUATING THE COST-EFFECTIVENESS OF THERAPY CONVERSION FROM BASAL INSULIN TO BIPHASIC INSULIN ASPART 30/70 IN PATIENTS WITH TYPE 2 DIABETES IN CHINA: A MODELING STUDY OF LONG-TERM COSTS AND HEALTH OUTCOMES

Value in Health ◽

10.1016/s1098-3015(11)73078-9 ◽

2010 ◽

Vol 13 (7) ◽

pp. A507

Author(s):

J Chang ◽

F Sun ◽

H Li

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Health Outcomes ◽

Insulin Aspart ◽

Basal Insulin ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Download Full-text

PDB7 LONG TERM COST EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30/70 VERSUS INSULIN GLARGINE IN INSULIN NAÏVE PATIENTS WITH TYPE-2 DIABETES POORLY CONTROLLED ON ORAL HYPOGLYCEMIC AGENTS IN DANISH, DUTCH, FINNISH, FRENCH, GERMAN, NORWEGIAN, SPANISH, SWEDISH AND UK SETTINGS

Value in Health ◽

10.1016/s1098-3015(10)65950-5 ◽

2004 ◽

Vol 7 (6) ◽

pp. 736-737 ◽

Author(s):

M Lammert ◽

AJ Palmer ◽

S Roze ◽

ME Minshall ◽

WJ Valentine ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Insulin Aspart ◽

Hypoglycemic Agents ◽

Oral Hypoglycemic Agents ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

DB3 DECREASED RATES OF MAJOR HYPOGLYCAEMIC EVENTS LEAD TO IMPROVED LONG TERM COST EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30/70 VERSUS BIPHASIC HUMAN INSULIN 30 IN TYPE 2 DIABETIC SUBJECTS IN DANISH, FINNISH, GERMAN, NORWEGIAN, SPANISH, SWEDISH, AND UK SETTINGS

Value in Health ◽

10.1016/s1098-3015(10)65672-0 ◽

2004 ◽

Vol 7 (6) ◽

pp. 649 ◽

Author(s):

M Lammert ◽

AJ Palmer ◽

S Roze ◽

ME Minshall ◽

WJ Valentine

Keyword(s):

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Type 2 Diabetic

Download Full-text

Cost-Effectiveness of Switching to Biphasic Insulin Aspart 30 from Human Insulin in Patients with Poorly Controlled Type 2 Diabetes in South Korea

Value in Health ◽

10.1111/j.1524-4733.2009.00628.x ◽

2009 ◽

Vol 12 ◽

pp. S55-S61 ◽

Author(s):

Kyoung Hee Lee ◽

Se Jin Seo ◽

Jayne Smith-Palmer ◽

James L. Palmer ◽

Jeremy White ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

South Korea ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

DB1 PROJECTED COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 IN TYPE 2 DIABETES PATIENTS SWITCHED FROM BIPHASIC HUMAN INSULIN IN THE UNITED STATES

Value in Health ◽

10.1016/s1098-3015(10)73111-9 ◽

2009 ◽

Vol 12 (3) ◽

pp. A10 ◽

Author(s):

M Aagren ◽

TL Thomsen ◽

VK Knudsen

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

The United States ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text